Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma

Journal of cutaneous pathology

Volumn 43, Issue 9, 2016, Pages 787-791

  Mochel, Mark C ^a   Ming, Michael E ^a   Imadojemu, Sotonye ^a   Gangadhar, Tara C ^b   Schuchter, Lynn M ^b   Elenitsas, Rosalie ^a   Payne, Aimee S ^a   Chu, Emily Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

bullous pemphigoid; dermatitis herpetiformis; drug reaction; immunotherapy; melanoma

Indexed keywords

ANTINEOPLASTIC AGENT; IPILIMUMAB; MONOCLONAL ANTIBODY; PEMBROLIZUMAB;

ADULT; AUTOIMMUNE DISEASE; BULLOUS PEMPHIGOID; CASE REPORT; CHEMICALLY INDUCED; DERMATITIS HERPETIFORMIS; DRUG ERUPTIONS; FEMALE; HUMAN; MALE; MELANOMA; MIDDLE AGED; PATHOLOGY; SECONDARY; SKIN NEOPLASMS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; DERMATITIS HERPETIFORMIS; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PEMPHIGOID, BULLOUS; SKIN NEOPLASMS;

EID: 85027942456     PISSN: None     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12735     Document Type: Article

References (33)